Evolving Role of BTK Inhibitors in CLL: Sequencing, Combinations, and Novel Agents

Content Format:

Multimedia

Credit Type:

ABIM MOC | ACPE | AMA | ANCC

Credits:

1.00
CAR T-Cell Therapy: Expert Guidance for Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC with Pharmacotherapy Credit

Credits:

1.00
Independent Conference Coverage of the IASLC 2022 World Conference on Lung Cancer

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Menin Inhibition in Acute MLL Rearranged Leukemias: A New Target for Precision Care

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Evolving CLL Treatment Recommendations

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Key Ongoing Clinical Trials in HR-Positive/HER2-Negative Early-Stage Breast Cancer

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Immune Checkpoint Inhibition in Early-Stage TNBC

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Small Cell Lung Cancer: Applying the Latest Developments in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
New Advances in Prostate Cancer Care: Emerging Therapies Targeting PSMA

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
CCO Independent Conference Highlights of the European Hematology Association 2022 Congress

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Key Studies in Lung Cancer: Independent Conference Coverage of ASCO 2022

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Key Studies in Gastrointestinal Cancers: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Assessing Measurable Residual Disease in Chronic Lymphocytic Leukemia

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Addressing Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Key Studies in Breast and Gynecologic Cancers: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
Evolution in Expert Recommendations for CLL Treatment

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Indolent B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Actionable Biomarkers in Lung Cancer: Clinical Applications for Nursing Practice

Content Format:

Multimedia

Credit Type:

ANCC

Credits:

1.00
Measurable Residual Disease Assessment in Chronic Lymphocytic Leukemia

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
A Case-Based Focus on Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Biomarker Testing to Optimize NSCLC Care: Multidisciplinary Perspectives

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Clinical and Guideline Updates on Systemic Therapies for Hepatocellular Carcinoma

Content Format:

Video

Credit Type:

ACPE

Credits:

1.00
Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
New Treatment Strategies in Aggressive B-Cell Lymphomas: Advances, Application, and a Glimpse of the Future

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
From Biomarkers to Treatment: The New Need-to-Know in Early Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Biomarkers in Gastrointestinal Cancer: Expert Perspectives and Guidance for Individualized Treatment

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Evolving Treatment Paradigms for Gynecologic Malignancies: Application for Current and Future Practice

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Biomarker-Driven Lung Cancer Care: Application of New Standards and the Latest Research

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Multidisciplinary Perspectives on CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Multidisciplinary Perspectives on Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Germline BRCA Testing and Targeting With Adjuvant Olaparib in HER2- EBC

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Precision Medicine Approaches in the Management of Cholangiocarcinoma

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Key Advances in Gynecologic Cancers: Expert Insight for Incorporating New Clinical Evidence

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.25
Risk Assessment and Ki-67 Testing in HR-Positive/HER2-Negative EBC for Adjuvant Abemaciclib

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Key Studies in Multiple Myeloma: Independent Conference Coverage of ASH 2021

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
HER2, HER3, and TROP2: An Update on Novel Treatments for Key Targets

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Key Studies in Myelodysplastic Syndromes and Myeloproliferative Neoplasms: Independent Conference Coverage of the 2021 ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Key Studies in Lymphomas and CLL: Independent Conference Coverage of ASH 2021

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Acute and Chronic GVHD: A Deep Dive Into Current Approaches, Near-Term Progress, and Future Directions

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Smarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.50
Biomarkers in Gastrointestinal Cancer: Applying the Latest Data in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Applying Current Evidence on Tailored Therapeutic Strategies to Improve Outcomes for Patients With Myeloproliferative Neoplasms

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Expert Analysis: CCO Independent Conference Highlights of the 2022 ASCO Gastrointestinal Cancers Symposium (GICS)

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Individualizing Frontline Therapy for Patients With Chronic Lymphocytic Leukemia: Putting Evidence Into Practice

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
State-of-the-Art Biomarker Testing in Gastrointestinal Cancer: Guidance for Oncologists and Pathologists

Content Format:

Multimedia

Credit Type:

ABIM MOC | AMA

Credits:

1.25
Key Studies in Urothelial, Prostate, and Kidney Cancer: CCO Independent Conference Highlights of the 2022 Genitourinary Cancers Symposium

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Overview of Risk Assessment and Biomarker Testing to Inform Treatment in HER2-Negative Early Breast Cancer

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Key Studies in Leukemias: Independent Conference Coverage of ASH 2021

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Targeting BCMA in Multiple Myeloma: Evidence-Based Guidance for Current and Near Future Clinical Integration

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
PARP Combination Therapies: A New Horizon in Prostate Cancer Care

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
New Agents and Evolving Strategies in Prostate Cancer: Focus on Castration-Sensitive Disease

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Choosing Frontline Therapy in Chronic Lymphocytic Leukemia

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Essentials to Deliver Quality Care for Patients With CML: A Team Approach

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Key Studies in Nonmalignant Hematology: Independent Conference Coverage of ASH 2021

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Advances and Recent Approvals for Immunotherapy and Targeted Therapies in Cervical Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Adopting New Approaches in AL Amyloidosis: Expert Perspectives on Latest Evidence

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Managing Light-Chain Amyloidosis: Experts Respond to Your Questions on Optimizing Care

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Guidance on Treatment Advances in Acute Myeloid Leukemia

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Neuregulin-1 (NRG1): An Emerging Tumor-Agnostic Target

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Chronic Lymphocytic Leukemia: Applying the Latest Data in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Advances in Immune Thrombocytopenia: Expert Guidance to Navigate an Evolving Therapeutic Landscape

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Asparaginase-Based Treatments in Young and Older Adults With Acute Lymphoblastic Leukemia: Leveraging the Pediatric Experience

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
A Review of Current and Emerging Treatment Options for Myelodysplastic Syndromes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Key Studies in Genitourinary, Gastrointestinal, Breast, and Lung Cancers: CCO Independent Conference Highlights of the 2021 Virtual ESMO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Individualizing Cervical Cancer Care With Current and Emerging Practice-Changing Clinical Data for Cervical Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Cancer Conversations™ in RCC: Improving Outcomes With Immunotherapy and Targeted Agents

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
Independent Conference Coverage of the IASLC 2021 World Conference on Lung Cancer

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Acknowledging Patient Preferences (Goals) and Promoting Enrollment on Clinical Trials for Cervical Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Improving Provider Awareness About Healthcare Equity: Improving Access to Care for Women With Cervical Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Risk Factors, Screening, and Molecular Testing in Cervical Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Cancer Conversations™ Application of Individualized Treatment for MDS: Expert Guidance for Clinical Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Cancer Conversations™ PARP Inhibitors in Ovarian Cancer

Content Format:

Case Challenge

Credit Type:

AMA

Credits:

0.75
My Thoughts on Managing Patients With CML and Comorbidities

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Individualizing Ovarian Cancer Care With Current and Emerging Practice-Changing Clinical Data

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Acknowledging Patient Preferences (Goals) and Promoting Enrollment on Clinical Trials for Patients With Ovarian Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Risk Factors, Screening, and Molecular Testing in Ovarian Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Improving Provider Awareness About Healthcare Equity: Improving All Patients’ Access to Care in Ovarian Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Acknowledging Patient Preferences (Goals) and Promoting Enrollment on Clinical Trials for Endometrial Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Advances in Prostate Cancer: Androgen Deprivation Therapy Across the Disease Continuum

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.25
Individualizing Endometrial Cancer Care With Current and Emerging Practice-Changing Clinical Data

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Optimizing the Use of BTK Inhibitors in B-Cell Malignancies: Addressing BTK Inhibitor Toxicities

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Risk Factors, Molecular Testing and Screening in Endometrial Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Improving Provider Awareness About Healthcare Equity: Improving Endometrial Cancer Patients’ Access To Care

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
An Expert’s Guide to ESMO 2021: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Key Studies in Genitourinary Cancers: CCO Independent Conference Highlights of the 2021 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Key Studies in NSCLC: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Key Studies in Breast and Gynecologic Cancers: Independent Conference Coverage of the 2021 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
Key Studies in Skin Cancer: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
EGFR-Mutant Advanced NSCLC: Global Insights on Testing and Treatment Planning

Content Format:

Multimedia

Credit Type:

AMA | ANCC

Credits:

1.00
Managing Serious Adverse Events Associated with BTK Inhibitor Treatment

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 2: Patient Strategies for Self-Management

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
Exploring the Abundance of Biomarkers in Lung Cancer: Current Applications and Future Prospects for Precision Medicine

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
Adverse Events Associated with BTK Inhibitor Treatment

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
State-of-the-Art Care for Patients With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
New Advances in Follicular Lymphoma: A Focus on the Expanding Role of PI3K Inhibitors

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
PARP Inhibitor Combinations in Prostate Cancer: Expanding Treatment Options to Broader Patient Populations

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
Staying on TRK: Addressing Clinical Challenges and Improving Outcomes in NTRK Fusion Positive Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Managing Immune-Related Adverse Events: A Nursing Perspective

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Dosing, Administration, and Risks/Benefits of Treatment Strategies for UC: A Patient’s Perspective

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Mastering Current Management of CLL

Content Format:

Multimedia

Credit Type:

ACPE

Credits:

1.00
MedicalMinute: Emerging Guidance on COVID-19 Vaccination in Patients Receiving Immune Checkpoint Inhibitors

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Transforming Modern Care in NSCLC: Navigating Advances in New and Emerging Biomarkers to Guide Precision Treatment Decisions

Content Format:

Multimedia

Credit Type:

ABPath MOC | AMA

Credits:

1.50
Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Selecting First-line Therapy for Advanced UC: Chemotherapy vs Immunotherapy

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Treatment-Refractory Advanced Urothelial Cancer: What to Do After Chemotherapy and/or Immunotherapy

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Emerging Role for Immunotherapy in Localized Bladder Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Individualized Patient Care: Role of Biomarkers in Urothelial Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Cancer Conversations™: Experts Discuss and Debate Optimal Treatment of Relapsed/Refractory Multiple Myeloma

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
Key Studies in Lung Cancer: Independent Conference Coverage of the World Conference on Lung Cancer 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.50
New Approaches in Urothelial Carcinoma: Expert Guidance to Improve Patient Outcomes

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Beyond BRCA: Exploring PARP Combinations in Prostate Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
MedicalMinute: What to Expect When Your Patient Is Starting Immune Checkpoint Inhibitor–Based Therapy

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
MedicalMinute: A Practical Guide to Managing Common Immune-Related Adverse Events

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
MedicalMinute: A Practical Guide to Managing Less Common Immune-Related Adverse Events

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Key Studies in Myeloma: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
Immune Checkpoint Inhibitors for Hepatobiliary Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.25
CCO Independent Conference Highlights of the Virtual 2021 Gastrointestinal (GI) Cancers Symposium

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Key Studies in Lymphomas: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Key Studies in Myelodysplastic Syndromes and Myeloproliferative Neoplasms: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Key Studies in Leukemias: Independent Conference Coverage of ASH 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
Key Studies in Nonmalignant Hematology: Independent Conference Coverage of ASH 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Case Discussion: Relapsed ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Case Discussion: Management of Immune-Related AEs

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Role of Radiation Therapy in the Management of ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Key Clinical Trials of Immunotherapy in SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Managing AEs With Enfortumab Vedotin: A Patient Case Example

Content Format:

Case Challenge

Credit Type:

--

Credits:

--
Managing AEs With Erdafitinib: A Patient Case Example

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Understanding the Therapeutic Antibody–Drug Conjugate Enfortumab Vedotin

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Clinical Advances in Immune Thrombocytopenia: Integrating New Therapies

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.50
Case Discussion: Newly Diagnosed ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Rationale for Using Immunotherapy in the Treatment of ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Overview of Immunotherapy Options for Treatment-Naive ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Overview of Therapeutic Options for Relapsed ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Understanding the FGFR-Targeted Therapy Erdafitinib

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Management of Limited-Stage SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Therapeutic Strategies for Pretreated Metastatic UC: A Nursing Perspective

Content Format:

Multimedia

Credit Type:

--

Credits:

--
NSCLC Biomarkers: Expert Insights on New Targets, Testing Options, and Personalized Treatment

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

1.00
Therapeutic Strategies for Pretreated Metastatic UC: A Pharmacy Perspective

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress

Content Format:

Case Challenge

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Applying The Results of Practice-Changing Clinical Research To Patient Care in Hepatocellular Carcinoma

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Accessing KRASG12C: A New Anticancer Approach

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Emerging Therapies and Novel Approaches Targeting BCMA in Myeloma

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance

Content Format:

Video

Credit Type:

--

Credits:

--
Cases in CLL: Third-line Treatment Following BTK Inhibitor– and Venetoclax-Based Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Options for an Older Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Applying New Evidence to Optimize Care in Advanced Prostate Cancer

Content Format:

Text Module

Credit Type:

--

Credits:

--
Cases in CLL: Patient Progressing on BR With Subsequent Ibrutinib Intolerance

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: High-Risk Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Fit, Younger Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Second-Line Therapy Following Chemoimmunotherapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Key Studies in Lung Cancer: Independent Conference Coverage of the ASCO 2020 Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Critical Advances in CLL: Building on Recent Progress for Community Practices

Content Format:

Case Challenge

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Hematologic Malignancies: A Review of Key Clinical Studies

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Novel Therapies for Relapsed or Refractory HER2-Positive Metastatic Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Key Studies in Genitourinary Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
PARP Inhibitors for Targeting DNA Repair in Prostate Cancer

Content Format:

Video

Credit Type:

--

Credits:

--
Current and Future Therapeutic Strategies for Multiple Myeloma

Content Format:

Video

Credit Type:

--

Credits:

--
Expert Guidance on Therapeutic Strategies for Multiple Myeloma

Content Format:

Text Module

Credit Type:

--

Credits:

--
Bispecific Antibodies in Multiple Tumor Types

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Integrating Oncology Treatment Biosimilars Into Clinical Practice

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Expert Guidance on Optimizing Treatment Strategies for Acute Lymphoblastic Leukemia

Content Format:

Text Module

Credit Type:

--

Credits:

--
Expert View on Managing Patients With CLL Using Targeted Therapies

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Advancing the Role of BTK Inhibitors in B-Cell Malignancies: Expert Guidance to Refine Clinical Management Strategies

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.75
Immunotherapy in Urothelial Bladder Cancer: Current Treatments and Emerging Research

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Preview of ASH 2019: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

1.00
Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges

Content Format:

Multimedia

Credit Type:

--

Credits:

--
The Evolving Role of VEGF Targeted Agents in Treating Solid Tumors

Content Format:

Text Module

Credit Type:

--

Credits:

--
Advances in Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer: Why, Who, and How

Content Format:

Multimedia

Credit Type:

ABPath MOC | AMA

Credits:

1.00
B-Cell Malignancies—Expert Guidance on BTK Inhibitors for Today’s Clinic

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Precise Therapy for Patients With AML: Experts Discuss Clinical Challenges and Future Directions

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Evolution in the Care of NSCLC: Keeping Pace With Today’s Best Practices

Content Format:

Multimedia

Credit Type:

--

Credits:

--